Veterinary Vaccines

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

A. Companion Animal Vaccines

B. Livestock Vaccines

Porcine Vaccines

Bovine Vaccines

Poultry Vaccines

Ovine Vaccines

Equine Vaccines

Other Animal Vaccines

II. EXECUTIVE SUMMARY

1. Industry Overview & Outlook

Global Animal Health Care Industry - A Brief Review

Table 1: Global Animal Health Products Market by Region (2007): Percentage Share Breakdown by Value Sales for Europe, North America, Latin America and Rest of World (includes corresponding Graph/Chart)

Table 2: Global Animal Health Products Market by Product Group (2007): Percentage Share Breakdown by Value sales for Parasiticides, Vaccines, Anti-Infectives, Medical Feed Additives and Other Pharmaceuticals (includes corresponding Graph/Chart)

Scope of the Report

Current And Future Analysis

2. Market Trends & Issues

Companion Animal Vaccines: Trailing on a High Growth Track

OTC Market: A Potential Threat for Veterinarians

Parasiticides, Systemic Agents To Drive The Market

Taxonomy of Vaccines

Bird Flu - The Aftermath

Vaccination - Critical for Controlling Avian Influenza Virus

3. Product Overview

Vaccines - An Evolutionary Scan

Contribution of Animal Research to Vaccine Production

Veterinary Medicines- A Brief Review

Preventive Medicines

Therapeutic Medicines

Others

Veterinary Vaccines - An Essential Component of Animal Health Care

What Does A Veterinary Vaccine Do?

Classification of Veterinary Vaccines

Companion Animal Vaccines

Canine Vaccines

Feline Vaccines

Livestock Vaccines

Bovine Vaccines

Poultry Vaccines

Ovine Vaccines

Porcine Vaccines

Equine Vaccines

Aquaculture Vaccines

A Tabular Analysis on Select Animal Diseases Controlled by Vaccines

Vaccination and Its Reactions

Veterinary Vaccines- Latest Breakthroughs

Marker vaccines

DNA vaccines

Gene-deleted vaccines

Viral-vectored vaccines

4. Notes on Select Animal Diseases

Brucellosis

Tuberculosis

Johne’s disease

Spirochete Associated Diseases

Respiratory Disease in Goats, Sheep, and Cattle

Porcine Respiratory Diseases

Mastitis

African Swine Fever

Avian Influenza

East Coast Fever

Hemorrhagic Septicemia

Foot-And-Mouth Disease

Japanese Encephalitis

Rift Valley Fever

5. Product Innovations/Introductions

Intervet Develops Bluetongue Vaccine

Agroinsuvet Introduces New Vaccines

Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for Poultry Industry

Intervet & FLI Develop Dual Vaccine Prototype for Birds

Schering-Plough Receives USDA License for its Rhusigen™ Erysipelas Vaccine

USDA Approves Use of PreveNile™ Vaccine for Horses

Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine

Boehringer Ingelheim’s Swine Vaccine Gains Approval in Australia

Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs

Embrex’s Poultry Vaccine Inovocox Gets USDA Approval

Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine

USDA Grants Conditional License for Necrotic Enteritis Vaccine

Fort Dodge Receives USDA License for Pyramid®10

USDA Licenses Use of Fort Dodge’s Suvaxyn® PCV2 Vaccine in Pigs

USDA Grants Conditional License to Pfizer’s New Canine Vaccine

Continuum ™ DAP Vaccine from Intervet

Lohmann Unveils Vaccine for Gumboro Disease

New Vaccine for Bovine Respiratory Disease

Corpoica & Limor Introduce Cattle Vaccine

Chiron to Roll Out Rabies Vaccine in China

Heska Launches Feline UltraNasal(TM) Vaccines

Merial Unveils Two PUREVAX® Respiratory Vaccines

6. Recent Industry Activity

Bayer Inks Agreement with Juvaris

Pfizer Inks Agreement with IVT

Vivalis Extends Research Collaboration with Kaketsuken

Merial Bags Major Australian Contract

USDA Approves Intervet Vaccine

Merial Pockets Ancare

Heska Revises Distribution Agreement with AgriLabs

Animal Health International Acquires Kane Veterinary

Industrial Equity Investments Pockets Arysta LifeScience

Henry Schein Acquires W&J Dunlop

Tecnovax Establishes New Facility

Pingtung Agricultural to Set Up an Exclusive Veterinary Park

Ouro Fino To Expand Veterinary Product Suite

Alpharma Acquires Yantai Jinhai

Pfizer Animal Health Acquires Embrex

Schering-Plough Acquires Intervet

Schering-Plough Acquires Organon

Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer

Crucell Licenses PER.C6® Technology to Pfizer Animal Health

CVRL to Synthesize New Animal Vaccines

Pfizer to Shut Down Omaha Animal Vaccine Center

IGI Inc Licenses Novasomes to Novavax

IPB Collaborates with Shigeta for Vaccine Production

Suguna Poultry Steps into Livestock Vaccine Production Business

European Medicines Agency Grants Community Authorization for Nobilis Influenza H7N1

AVANT & Pfizer Collaborate to Develop Animal Vaccines

Intervet Acquires FMD Vaccine Production Facility from Bayer Healthcare

CFIA Authorizes Bioniche E. Coli O157: H7 Cattle Vaccine for Field Use

Hemispherx Biopharma Acquires DOGS Molecule Patent

Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala

Cryosite and Animal Health Australia Form Partnership

Hester Pharmaceuticals Plans Capacity Expansion

Biovet Pvt Ltd to Set up Animal Vaccine Plant in Karnataka

IPB and Shigeta Establish JV for Production of CLOSE 5.1 Vaccine

IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune

Bioject Signs Three Agreements With Merial

PetCARE signs US distribution agreement with Butler Animal Health Supply

Poultry Vaccine to be produced in Vladimir

DEFRA Against Vaccine Usage For Bird Flu

Butler & Burns Complete Business Merger

Ivax Completes Phoenix Scientific’s Acquisition

Crucell Signs Licensing Agreement with Merial

Charlesbank Acquires Walco

Imugene Signs an Agreement with Abic Biological

Vical Licenses Core Technology to Merial

Pfizer Acquires CSL’s Veterinary Vaccines Business

Antigenics Sells Feline Leukemia Vaccine Unit

Embrex Establishes Novel In Ovo Vaccine Plant

Indian Immunological Bags Order for Foot and Mouth Disease Vaccine

Crucell Issues West Nile Virus Vaccine License to Pfizer

Kimron Veterinary Signs a License Agreement with Crucell

Akzo Constructs Manufacturing Unit in Boxmeer

7. Research and Development

Scientists Develop New Vaccine Against Disease Related to PCV2

Auburn University and Vaxin Researchers Develop Avian Flu Vaccine

UK Researchers Develop In-Shell Vaccine for Chicks

Researchers in Vietnam Decode the H5N1 Virus Gene

Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus

University of Warwick Develops Protecting Virus Method

New Treatment Measure Against Ovine Salmonella & Brucellosis

ICAR Develops Indigenous Bird Flu Vaccine

St. Jude Develops Flu Virus Vaccine through Reverse Genetics

Researchers Develop Vaccine for Swine Disease

Researchers Develop Experimental Vaccine Against 1918 Influenza Virus

Study Proves Effectiveness of Intradermal Vaccine Administration in Rabbits

CEL-SCI’s CEL-1000 Peptide Shows Adjuvant Activity

Progress in Vaccine for Canine Cancer

Vaccine for Avian Flu Developed

Vector for DNA Vaccine Developed

Bovine Herpesvirus 1 VP22Improves the Efficiency of DNA Vaccine

Vaccine Against Canine Flu Underway

Study on Immunity in Dogs

New Sheep Vaccine in Clinical Trials

Commercialization of Poultry Vaccine Underway

Vaccine for B. Anthracis Developed

Efficacy of E.Coli 0157 Vaccine Demonstrated

Calgary-based Biotechnology Company to develop Oral Vaccine for Cattle Against Pneumonia

Vaccine for Tick-Borne Disease Underway

Feline Immunodeficiency Virus Rhinotracheitis Vaccine for Cats Under Trials

Japanese Study on Bird Flu Vaccine

8. Focus on Select Global Players

AVANT Immunotherapeutics, Inc (USA)

Megan Health, Inc. (USA)

Bayer HealthCare AG (Germany)

Fort Dodge Animal Health (USA)

Heska Corporation (USA)

Imugene Limited (Australia)

Merial Animal Health Ltd. (UK)

Pfizer, Inc. (USA)

Embrex, Inc. (USA)

Protein Sciences Corporation (USA)

Schering-Plough Corporation (USA)

Intervet International B.V. (The Netherlands)

Intervet, Inc. (USA)

Virbac Corporation (USA)

9. Global Market Perspective

Table 3: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 4: World Long-term Projections for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 5: World 10-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 6: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 7: World Long-term Projections for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart)

Table 8: World 10-Year Perspective for Companion Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 9: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 10: World Long-term Projections for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 11: World 10-Year Perspective for Companion Animal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines & Feline Vaccines Markets for Years 2003, 2008 & 2012

Table 12: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 13: World Long-term Projections for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 14: World 10 - Year Perspective for Canine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 15: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 16: World Long-term Projections for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 17: World 10 - Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 18: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 19: World Long-term Projections for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 20: World 10 - Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 21: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 22: World Long-term Projections for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 23: World 10-Year Perspective for Livestock Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 24: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 25: World Long-term Projections for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 26: World 10 - Year Perspective for Porcine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 27: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 28: World Long-term Projections for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 29: World 10 - Year Perspective for Bovine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 30: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 31: World Long-term Projections for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 32: World 10 - Year Perspective for Poultry Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 33: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 34: World Long-term Projections for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 35: World 10 - Year Perspective for Ovine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 36: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 37: World Long-term Projections for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 38: World 10 - Year Perspective for Equine Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 39: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 40: World Long-term Projections for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 41: World 10 - Year Perspective for Other Animal Vaccines by Geographic region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Current & Future Analysis

H5N1 Virus: A Conundrum for the US Industry

Rabies Cases in the US (2005)

Historic Data

Table 42: Leading Players in the US Rabies Vaccines Market (1995): Percentage Market Share for Pfizer, Fort Dodge, Solvay, Rhone Merieux and Others (includes corresponding Graph/Chart)

Strategic Developments

Product Launches/ Developments

Key US Players

AVANT Immunotherapeutics, Inc (USA)

Megan Health Inc

Fort Dodge Animal Health

Heska Corporation

Intervet, Inc

Pfizer Inc

Embrex, Inc

Protein Sciences Corporation

Schering-Plough Corporation

Virbac Corporation

B. Market Analytics

Table 43: US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 44: US Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 45: US 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2. Europe

A. Market Analysis

Current & Future Analysis

By Segment

Strategic Development

B. Market Analytics

Table 46: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 47: European Long-term Projections for Veterinary Vaccines by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 48: European 10-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, United Kingdom and Rest of Europe for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 49: European Recent Past, Current & Future Analysis of Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 50: European Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 51: European 10 - Year Perspective for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2a. France

A. Market Analysis

Current & Future Analysis

Strategic Development

B. Market Analytics

Table 52: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 53: French Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 54: French 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2b. Germany

A. Market Analysis

Current & Future Analysis

Strategic Developments

Key German Players

Bayer HealthCare AG

B. Market Analytics

Table 55: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/ Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 56: German Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, & Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 57: German 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines & Equine Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2c. Italy

Market Analysis

Table 58: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 59: Italian Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 60: Italian 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2d. The United Kingdom

A. Market Analysis

Current & Future Analysis

Strategic Corporate Developments

Product Launches

Key Player in UK

Merial Animal Health Ltd

B. Market Analytics

Table 61: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 62: UK Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 63: UK 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2e. Rest of Europe

A. Market Analysis

Overview

A Note on Danish Veterinary Services

The 2002 Standards of Danish Medicines recommend test for antibody inducing fragments in veterinary vaccines

Hungary Vaccinates Birds Across Zoos

Russia Mass-Produces Vaccines Against Avian Flu

Product Launches/Developments

Strategic Developments

Focus on Select Players

Intervet International B.V. (The Netherlands)

B. Market Analytics

Table 64: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 65: Rest of Europe Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)

Table 66: Rest of Europe 10-Year Perspective for Veterinary Vaccines by Product/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

3. Rest of World

A. Market Analysis

Overview

Focus on Select Regions

Canada

Overview of Canadian Animal Health Industry

Import and Manufacture of Veterinary Biologics

First to Access E. coli 0157: H7 Vaccine

China

An Emerging Veterinary Vaccine Hub

China Initiates Mass Vaccination Campaign Against Bird Flu Virus

Australia

A Note on Australian Veterinary Therapeutics Market

India

ICAR Develops Indigenous Bird Flu Vaccine

Thailand

Japan & Thailand to Cooperate for Developing Bird Flu Vaccine

Malaysia

Malaysia Initiates Measures to Deal with Potential Flu Pandemic

Kazakhstan

Kazakhstan Takes Proactive Measures Against Bird Flu

North Korea

North Korea Develops Bird Flu Vaccine

Vietnam

Vietnam to Mass-Produce Bird Flu Vaccines

Vietnam Imports Bird Flu Vaccine from Russia

Egypt

Egypt Reports H5N1 Infection in Vaccinated Flocks

Kenya

Kenya to Mass-Manufacture Vaccines Against Rift Valley Fever

Strategic Developments

Product Launches/Developments

Focus on Select players

Immunovaccine Technologies Inc. (Canada)

Imugene Limited (Australia)

Indian Immunologicals Ltd (India)

B. Market Analytics

Table 67: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 68: Rest of World Long-term Projections for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 69: Rest of World 10-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines & Feline Vaccines), Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE